We are experts in biotech value creation
Pharmagellan’s free biotech newsletter is read by thousands of successful drug industry executives and investors — and those who aspire to join their ranks.
Get “news you can use” about clinical trial analysis, R&D strategy, and financial modeling via email once every 1-2 weeks — for free!
“Wonderful analysis, critical dissection, and articulation. A joy to read.” — Pharma head of new product planning
“One of the best newsletter emails I’ve gotten in months.” — Biotech co-founder & CEO
“Great email, I love this content. Quickly becoming a must read missive for me!” — Biotech director of corporate development
“These are great. Clear, short, easy reads and very educational.” — Biopharma BD consultant
“Top newsletter — cannot wait to read the next one.” — Pharma health economist
Our Pharmagellan Guides are trusted by executives, new hires, and students who work in and around the biotech industry.
Discover how far you can go.
Pharmagellan unlocks the true value in your biotech development pipeline.
Many early-stage drug development projects don't progress if the team is stretched thin, and people and resources are focused on more advanced assets.
To fully realize the value of projects under development, these companies need external support that is both senior-level and hands-on.
Pharmagellan offers just that: expert advice and project execution to biotech and pharma companies willing to discover how far they can go. Learn more about what we do and how we can help.
RESEARCH & DEVELOPMENT
Preclinical, translational, and early clinical strategy and execution
COMMERCIAL & CORPORATE
Analysis and strategy for products, pipelines, and companies
Read our research.
